As you might be able to glean from the name, the demo for Space Warlord Baby Trading Simulator is incredibly odd. It’s an intergalactic stock market simulator that feels like a blend of blackjack, ...

Roguelikes are all the rage this year, and if you spent any time combing through the best Steam Next Fest demos, chances are that you played quite a few. One of the best roguelike demos that I found ...

Another search intelligence company has been gobbled up -- this time by Verve Group, the ad-technology company based in Stockholm. Verve will pay a total of €25.6 million for Captify Technologies in ...

Seattle Seahawks quarterback Drew Lock just announced the gender of his second child. The University of Missouri alum, 28, and his wife, Natalie Lock, whom he married in 2023, announced in a joint ...

EXCLUSIVE: Jack Henry Robbins is teaming with 20th Television to develop Nepo Baby, a new comedy series for Hulu, based on his viral character. In the show created by Robbins, the world’s least ...

Jefferies analysts called the proxy filing, which is a standard disclosure after a merger agreement, “much more intriguing than normal” given the regulatory turmoil it revealed. It’s not every day ...

Eli Lilly's $1.3B acquisition of Verve Therapeutics caused a sharp rally, but with shares above the buyout price, I recommend selling now. The main risks are the deal not closing, which could send ...

Eli Lilly LLY0.10%increase; green up pointing triangle agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

Eli Lilly has bought gene editing partner Verve Therapeutics for $1.3 billion, bringing in-house a pipeline of cardiovascular programs the Big Pharma had already secured a stake in. The two companies' ...